Castle Biosciences Inc (CSTL) Stock Price, Quote & News

Company Profile

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 866 788 9007

Website: castlebiosciences.com

Address:

505 S. Friendswood Drive, Suite 401, Friendswood, United States

RocketThief Sep. 12 at 7:08 PM

$CSTL low volume dip, adding as it falls

0 · Reply

NVDAMillionaire Sep. 8 at 4:24 PM

$CSTL Outstanding article that hits the mark on CSTL's current state. So if you want to refresh your CSTL insights or learn about CSTL from scratch, this is a must read. https://beyondspx.com/quote/CSTL/analysis/castle-biosciences-unlocking-value-through-precision-diagnostics-and-strategic-expansion-nasdaq-cstl

1 · Reply

TheBearVsTheBull Sep. 4 at 3:32 PM

$LUCD $EXAS $ABBV $CSTL $MRK Anyone else who registered to the MolDX CAC meeting today should have received an email from MolDX and it looks like they CC’d everyone on the email. I see a lot of interesting names on there such as people from Exact, Abbivie, Merck, and CastleBiosciences 👀.

2 · Reply

BioTechNoir Sep. 2 at 6:42 PM

$CSTL GREEN

0 · Reply

BioTechNoir Aug. 29 at 1:28 AM

$CSTL when $30

0 · Reply

DarthGoat Aug. 28 at 4:32 PM

$CSTL OOOOUUTTT +18%

0 · Reply

MetaverseEdge Aug. 23 at 10:23 AM

$CSTL Castle Biosciences Inc is facing diagnostic adoption challenges and reimbursement pressure

0 · Reply

Dream2121 Aug. 16 at 7:36 PM

$CSTL Their Attopic Dermatitis test will come out before the end of the year. It will eliminate the Trial and Error in picking the right systemic medication in treating eczema. I think this will be huge because eczema is such a common condition among almost all ages.

0 · Reply